Analysis

Drug prices are expected to increase just 4.92 percent in 2019, driven primarily by specialty pharmaceuticals.

The departure of many would-be customers is increasingly narrowing the client base for the individual market.

Just a third of employees actually participate in financial wellness programs, even though many are having a hard time financially.

When it comes to retirement legislation such as that affecting Open MEPs, the devil will be in the details

How does a fiduciary with respect to a distributing plan under the 5-part test advise plan participants regarding rollovers?

According to a new analysis, Medicare for All would deliver significant savings on administration and drug costs, but increased demand for care would drive up spending.